Bayer Aktiengesellschaft is a German based pharmaceutical and life sciences company with a market cap of 58.08 bln EUR. The company’s stock price at the time of writing this description was 59.12 EUR, down 0.55% from the previous day (58.73 EUR - 59.52 EUR). The 52-week high for the stock is 67.99 EUR and the 52-week low is 46.7 EUR, giving it an average price over the last 50 days of 54.09 EUR and an average price over the last 200 days of 55.11 EUR, traded on XETRA exchange with a volume of 1,912,140 today (average daily volume of 2,598,526).
The most recent revenue data available for Bayer Aktiengesellschaft shows total revenues of 85.06 bln EUR in November 2020 ending September 30th 2020 and 100.54 bln EUR in August 4th 2020 ending June 30th 2020 respectively indicating that the company continues to perform well financially despite a global downturn due to COVID-19 pandemic resulting in lower profits year on year compared to 2019 when Bayer reported 113 bln Euro in full year sales revenue confirming that Bayer continue its steady financial performance despite challenging economic climate conditions towards end of 2020.
